カテゴリー： QYResearch, 世界

世界の人工関節感染症治療市場 2019年

【英語タイトル】Global Prosthetic Joint Infections Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X13818）・商品コード：DATA909X13818
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、人工関節感染症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他に、用途別には、病院、診療所、その他にセグメント区分し、人工関節感染症治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・人工関節感染症治療の世界市場概要
・人工関節感染症治療の製造コスト構成分析
・人工関節感染症治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・人工関節感染症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・人工関節感染症治療のセグメント分析（種類別）
（フシジン酸、酢酸レファムリン、MTF-101、TNP-2092、その他）
・人工関節感染症治療のセグメント分析（用途別）
（病院、診療所、その他）
・人工関節感染症治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Cempra Inc、Motif Bio Plc、Nabriva Therapeutics AG、Telephus Medical LLC、TenNor Therapeutics Ltd、）
・人工関節感染症治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Prosthetic Joint Infections Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Prosthetic Joint Infections Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prosthetic Joint Infections Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Prosthetic Joint Infections Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Prosthetic Joint Infections Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Cempra Inc
Motif Bio Plc
Nabriva Therapeutics AG
Telephus Medical LLC
TenNor Therapeutics Ltd
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Fusidic acid
Lefamulin Acetate
MTF-101
TNP-2092
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Prosthetic Joint Infections Treatment
1.1 Definition of Prosthetic Joint Infections Treatment
1.2 Prosthetic Joint Infections Treatment Segment by Type
1.2.1 Global Prosthetic Joint Infections Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Fusidic acid
1.2.3 Lefamulin Acetate
1.2.4 MTF-101
1.2.5 TNP-2092
1.2.6 Others
1.3 Prosthetic Joint Infections Treatment Segment by Applications
1.3.1 Global Prosthetic Joint Infections Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Prosthetic Joint Infections Treatment Overall Market
1.4.1 Global Prosthetic Joint Infections Treatment Revenue (2014-2025)
1.4.2 Global Prosthetic Joint Infections Treatment Production (2014-2025)
1.4.3 North America Prosthetic Joint Infections Treatment Status and Prospect (2014-2025)
1.4.4 Europe Prosthetic Joint Infections Treatment Status and Prospect (2014-2025)
1.4.5 China Prosthetic Joint Infections Treatment Status and Prospect (2014-2025)
1.4.6 Japan Prosthetic Joint Infections Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Prosthetic Joint Infections Treatment Status and Prospect (2014-2025)
1.4.8 India Prosthetic Joint Infections Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Prosthetic Joint Infections Treatment
2.3 Manufacturing Process Analysis of Prosthetic Joint Infections Treatment
2.4 Industry Chain Structure of Prosthetic Joint Infections Treatment

3 Development and Manufacturing Plants Analysis of Prosthetic Joint Infections Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Prosthetic Joint Infections Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Prosthetic Joint Infections Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Prosthetic Joint Infections Treatment Production and Capacity Analysis
4.2 Prosthetic Joint Infections Treatment Revenue Analysis
4.3 Prosthetic Joint Infections Treatment Price Analysis
4.4 Market Concentration Degree

5 Prosthetic Joint Infections Treatment Regional Market Analysis
5.1 Prosthetic Joint Infections Treatment Production by Regions
5.1.1 Global Prosthetic Joint Infections Treatment Production by Regions
5.1.2 Global Prosthetic Joint Infections Treatment Revenue by Regions
5.2 Prosthetic Joint Infections Treatment Consumption by Regions
5.3 North America Prosthetic Joint Infections Treatment Market Analysis
5.3.1 North America Prosthetic Joint Infections Treatment Production
5.3.2 North America Prosthetic Joint Infections Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Prosthetic Joint Infections Treatment Import and Export
5.4 Europe Prosthetic Joint Infections Treatment Market Analysis
5.4.1 Europe Prosthetic Joint Infections Treatment Production
5.4.2 Europe Prosthetic Joint Infections Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Prosthetic Joint Infections Treatment Import and Export
5.5 China Prosthetic Joint Infections Treatment Market Analysis
5.5.1 China Prosthetic Joint Infections Treatment Production
5.5.2 China Prosthetic Joint Infections Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Prosthetic Joint Infections Treatment Import and Export
5.6 Japan Prosthetic Joint Infections Treatment Market Analysis
5.6.1 Japan Prosthetic Joint Infections Treatment Production
5.6.2 Japan Prosthetic Joint Infections Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Prosthetic Joint Infections Treatment Import and Export
5.7 Southeast Asia Prosthetic Joint Infections Treatment Market Analysis
5.7.1 Southeast Asia Prosthetic Joint Infections Treatment Production
5.7.2 Southeast Asia Prosthetic Joint Infections Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Prosthetic Joint Infections Treatment Import and Export
5.8 India Prosthetic Joint Infections Treatment Market Analysis
5.8.1 India Prosthetic Joint Infections Treatment Production
5.8.2 India Prosthetic Joint Infections Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Prosthetic Joint Infections Treatment Import and Export

6 Prosthetic Joint Infections Treatment Segment Market Analysis (by Type)
6.1 Global Prosthetic Joint Infections Treatment Production by Type
6.2 Global Prosthetic Joint Infections Treatment Revenue by Type
6.3 Prosthetic Joint Infections Treatment Price by Type

7 Prosthetic Joint Infections Treatment Segment Market Analysis (by Application)
7.1 Global Prosthetic Joint Infections Treatment Consumption by Application
7.2 Global Prosthetic Joint Infections Treatment Consumption Market Share by Application (2014-2019)

8 Prosthetic Joint Infections Treatment Major Manufacturers Analysis
8.1 Cempra Inc
8.1.1 Cempra Inc Prosthetic Joint Infections Treatment Production Sites and Area Served
8.1.2 Cempra Inc Product Introduction, Application and Specification
8.1.3 Cempra Inc Prosthetic Joint Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Motif Bio Plc
8.2.1 Motif Bio Plc Prosthetic Joint Infections Treatment Production Sites and Area Served
8.2.2 Motif Bio Plc Product Introduction, Application and Specification
8.2.3 Motif Bio Plc Prosthetic Joint Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Nabriva Therapeutics AG
8.3.1 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Production Sites and Area Served
8.3.2 Nabriva Therapeutics AG Product Introduction, Application and Specification
8.3.3 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Telephus Medical LLC
8.4.1 Telephus Medical LLC Prosthetic Joint Infections Treatment Production Sites and Area Served
8.4.2 Telephus Medical LLC Product Introduction, Application and Specification
8.4.3 Telephus Medical LLC Prosthetic Joint Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 TenNor Therapeutics Ltd
8.5.1 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Production Sites and Area Served
8.5.2 TenNor Therapeutics Ltd Product Introduction, Application and Specification
8.5.3 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Prosthetic Joint Infections Treatment Market
9.1 Global Prosthetic Joint Infections Treatment Market Trend Analysis
9.1.1 Global Prosthetic Joint Infections Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Prosthetic Joint Infections Treatment Regional Market Trend
9.2.1 North America Prosthetic Joint Infections Treatment Forecast 2019-2025
9.2.2 Europe Prosthetic Joint Infections Treatment Forecast 2019-2025
9.2.3 China Prosthetic Joint Infections Treatment Forecast 2019-2025
9.2.4 Japan Prosthetic Joint Infections Treatment Forecast 2019-2025
9.2.5 Southeast Asia Prosthetic Joint Infections Treatment Forecast 2019-2025
9.2.6 India Prosthetic Joint Infections Treatment Forecast 2019-2025
9.3 Prosthetic Joint Infections Treatment Market Trend (Product Type)
9.4 Prosthetic Joint Infections Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Prosthetic Joint Infections Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Prosthetic Joint Infections Treatment
Table Global Prosthetic Joint Infections Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Prosthetic Joint Infections Treatment Production Market Share by Types in 2018
Figure Fusidic acid Product Picture
Figure Lefamulin Acetate Product Picture
Figure MTF-101 Product Picture
Figure TNP-2092 Product Picture
Figure Others Product Picture
Table Global Prosthetic Joint Infections Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Prosthetic Joint Infections Treatment Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Prosthetic Joint Infections Treatment Revenue (Million USD) (2014-2025)
Figure Global Prosthetic Joint Infections Treatment Production (K Pcs) (2014-2025)
Figure North America Prosthetic Joint Infections Treatment Market Size (Million USD) (2014-2025)
Figure Europe Prosthetic Joint Infections Treatment Market Size (Million USD) (2014-2025)
Figure China Prosthetic Joint Infections Treatment Market Size (Million USD) (2014-2025)
Figure Japan Prosthetic Joint Infections Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Prosthetic Joint Infections Treatment Market Size (Million USD) (2014-2025)
Figure India Prosthetic Joint Infections Treatment Market Size (Million USD) (2014-2025)
Table Prosthetic Joint Infections Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Prosthetic Joint Infections Treatment in 2018
Figure Manufacturing Process Analysis of Prosthetic Joint Infections Treatment
Figure Industry Chain Structure of Prosthetic Joint Infections Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Prosthetic Joint Infections Treatment Manufacturing Plants Distribution
Table Prosthetic Joint Infections Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Prosthetic Joint Infections Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Prosthetic Joint Infections Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Prosthetic Joint Infections Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Prosthetic Joint Infections Treatment Production Share by Manufacturers in 2018
Table Prosthetic Joint Infections Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Prosthetic Joint Infections Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Prosthetic Joint Infections Treatment Revenue Share by Manufacturers in 2018
Table Prosthetic Joint Infections Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Prosthetic Joint Infections Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Prosthetic Joint Infections Treatment Production Market Share by Regions 2014-2019
Figure Global Prosthetic Joint Infections Treatment Production Market Share by Regions in 2018
Table Global Prosthetic Joint Infections Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Prosthetic Joint Infections Treatment Revenue Market Share by Regions 2014-2019
Figure Global Prosthetic Joint Infections Treatment Revenue Market Share by Regions in 2018
Table Global Prosthetic Joint Infections Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Prosthetic Joint Infections Treatment Consumption Market Share by Regions 2014-2019
Figure North America Prosthetic Joint Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Prosthetic Joint Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Prosthetic Joint Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Prosthetic Joint Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Prosthetic Joint Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Prosthetic Joint Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure China Prosthetic Joint Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Prosthetic Joint Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Prosthetic Joint Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Prosthetic Joint Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Prosthetic Joint Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Prosthetic Joint Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Prosthetic Joint Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Prosthetic Joint Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Prosthetic Joint Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure India Prosthetic Joint Infections Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Prosthetic Joint Infections Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Prosthetic Joint Infections Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Prosthetic Joint Infections Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Prosthetic Joint Infections Treatment Market Share by Application (2014-2019)
Table Cempra Inc Prosthetic Joint Infections Treatment Production Sites and Area Served
Table Cempra Inc Prosthetic Joint Infections Treatment Product Introduction, Application and Specification
Table Cempra Inc Prosthetic Joint Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cempra Inc Prosthetic Joint Infections Treatment Production Growth Rate (2014-2019)
Table Cempra Inc Prosthetic Joint Infections Treatment Production Market Share (2014-2019)
Figure Cempra Inc Prosthetic Joint Infections Treatment Revenue Market Share (2014-2019)
Table Cempra Inc Prosthetic Joint Infections Treatment Main Business and Markets Served
Table Motif Bio Plc Prosthetic Joint Infections Treatment Production Sites and Area Served
Table Motif Bio Plc Prosthetic Joint Infections Treatment Product Introduction, Application and Specification
Table Motif Bio Plc Prosthetic Joint Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Motif Bio Plc Prosthetic Joint Infections Treatment Production Growth Rate (2014-2019)
Table Motif Bio Plc Prosthetic Joint Infections Treatment Production Market Share (2014-2019)
Figure Motif Bio Plc Prosthetic Joint Infections Treatment Revenue Market Share (2014-2019)
Table Motif Bio Plc Prosthetic Joint Infections Treatment Main Business and Markets Served
Table Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Production Sites and Area Served
Table Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Product Introduction, Application and Specification
Table Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Production Growth Rate (2014-2019)
Table Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Production Market Share (2014-2019)
Figure Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Revenue Market Share (2014-2019)
Table Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Main Business and Markets Served
Table Telephus Medical LLC Prosthetic Joint Infections Treatment Production Sites and Area Served
Table Telephus Medical LLC Prosthetic Joint Infections Treatment Product Introduction, Application and Specification
Table Telephus Medical LLC Prosthetic Joint Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Telephus Medical LLC Prosthetic Joint Infections Treatment Production Growth Rate (2014-2019)
Table Telephus Medical LLC Prosthetic Joint Infections Treatment Production Market Share (2014-2019)
Figure Telephus Medical LLC Prosthetic Joint Infections Treatment Revenue Market Share (2014-2019)
Table Telephus Medical LLC Prosthetic Joint Infections Treatment Main Business and Markets Served
Table TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Production Sites and Area Served
Table TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Product Introduction, Application and Specification
Table TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Production Growth Rate (2014-2019)
Table TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Production Market Share (2014-2019)
Figure TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Revenue Market Share (2014-2019)
Table TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Main Business and Markets Served
Figure Global Prosthetic Joint Infections Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Prosthetic Joint Infections Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Prosthetic Joint Infections Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Prosthetic Joint Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Prosthetic Joint Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Prosthetic Joint Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Prosthetic Joint Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Prosthetic Joint Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Prosthetic Joint Infections Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Prosthetic Joint Infections Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Prosthetic Joint Infections Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Prosthetic Joint Infections Treatment by Application (2019-2025)
Table Prosthetic Joint Infections Treatment Distributors List
Table Prosthetic Joint Infections Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Cempra Inc、Motif Bio Plc、Nabriva Therapeutics AG、Telephus Medical LLC、TenNor Therapeutics Ltd、

★調査レポート[世界の人工関節感染症治療市場 2019年] (コード：DATA909X13818)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の人工関節感染症治療市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の淋菌感染症治療市場 2019年
    DATA909X11919 / QYResearch / 2019年11月20日 / ※本調査レポートは、淋菌感染症治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他に、用途別には、クリニック、病院、その他にセグメント区分し、淋菌感染症治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・淋菌感染症治療の世界市場概要 ・淋菌感染症治療の製造コスト構成分析 ・淋菌感染症治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・淋菌感染症治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・淋菌感染症治療のセグメント分析（種類別） （クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他）...The global Neisseria Gonorrhoeae Infections Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Neisseria Gonorrhoeae Infections Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Neisseria Gonorrhoeae Infections Treatment market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Neisseria Gonorrhoeae Infections Treatment in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 関節疾患治療の世界市場：規模・現状・予測2019-2025
    DATA909X18607 / QYResearch / 2019年11月25日 / ※当調査レポートでは、関節疾患治療の世界市場について調査・分析し、関節疾患治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物療法、リハビリテーション、外科手術）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の関節疾患治療市場動向 ・主要企業別マーケットシェア ・関節疾患治療の種類別市場規模2014-2019 （薬物療法、リハビリテーション、外科手術） ・関節疾患治療の用途別市場規模2014-2019 （病院、診療所、その他） ・関節疾患治療の北米市場：主要企業・種類別/用途別市場規模 ・関節疾患治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Joint disease is defined as any type of injury or inflammation or disease that affects the joints of the body. Joint disease can range from acute to very chronic, excruciatingly painful or simply nagging and uncomfortable.In 2018, the global Joint Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Joint Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Joint Disease Therapeutics development in...
  • 世界のライノウイルス感染薬市場 2019年
    DATA909X14407 / QYResearch / 2019年11月20日 / ※本調査レポートは、ライノウイルス感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他に、用途別には、クリニック、病院、その他にセグメント区分し、ライノウイルス感染薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ライノウイルス感染薬の世界市場概要 ・ライノウイルス感染薬の製造コスト構成分析 ・ライノウイルス感染薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ライノウイルス感染薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ライノウイルス感染薬のセグメント分析（種類別） （塩化セチルピリジニウム、ヒトライノウイルス（多価）ワクチン、KR-22809、その他）...The global Rhinovirus Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rhinovirus Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rhinovirus Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rhinovirus Infections Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の耐性緑膿菌感染症薬市場 2019年
    DATA909X14315 / QYResearch / 2019年11月20日 / ※本調査レポートは、耐性緑膿菌感染症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、半合成ペニシリン、セファロスポリン、ラクタム薬、その他に、用途別には、病院、診療所、在宅ケアにセグメント区分し、耐性緑膿菌感染症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・耐性緑膿菌感染症薬の世界市場概要 ・耐性緑膿菌感染症薬の製造コスト構成分析 ・耐性緑膿菌感染症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・耐性緑膿菌感染症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・耐性緑膿菌感染症薬のセグメント分析（種類別） （半合成ペニシリン、セファロスポリン、ラクタム薬、その他）...The global Resistant Pseudomonas Aeruginosa Infections Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Resistant Pseudomonas Aeruginosa Infections Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Resistant Pseudomonas Aeruginosa Infections Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Resistant Pseudomonas Aeruginosa Infections Drugs in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のインフルエンザAウイルス、H3N2サブタイプ感染薬市場 2019年
    DATA909X09790 / QYResearch / 2019年11月20日 / ※本調査レポートは、インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、NEO-8877、NP-025、NSC-61610、NVINF-1、その他に、用途別には、クリニック、病院、その他にセグメント区分し、インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・インフルエンザAウイルス、H3N2サブタイプ感染薬の世界市場概要 ・インフルエンザAウイルス、H3N2サブタイプ感染薬の製造コスト構成分析 ・インフルエンザAウイルス、H3N2サブタイプ感染薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・インフルエンザAウイルス、H3N2サブタイプ感染薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・インフルエンザAウイルス、H3N2サブタイプ感染薬のセグメント分析（種類別） （NEO-8877、NP-025、NSC-61610、NVINF-1、その他）...The global Influenza A Virus, H3N2 Subtype Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Influenza A Virus, H3N2 Subtype Infections Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Influenza A Virus, H3N2 Subtype Infections Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Influenza A Virus, H3N2 Subtype Infections Drug in...

    • ◆H&Iグローバルリサーチのお客様（例）◆